tiprankstipranks
Trending News
More News >
Rhythm Pharmaceuticals (RYTM)
:RYTM
US Market

Rhythm Pharmaceuticals (RYTM) Income Statement

Compare
567 Followers

Rhythm Pharmaceuticals Income Statement

Last quarter (Q3 2025), Rhythm Pharmaceuticals's total revenue was $51.30M, an increase of 54.28% from the same quarter last year. In Q3, Rhythm Pharmaceuticals's net income was $-52.90M. See Rhythm Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 130.13M$ 77.43M$ 23.64M$ 3.15M$ 0.00
Gross Profit
$ 116.76M$ 68.13M$ 21.50M$ 2.56M$ -690.00K
Operating Expenses
$ 382.26M$ 252.48M$ 200.66M$ 172.61M$ 135.88M
Depreciation and Amortization
$ 1.56M$ 1.76M$ 1.67M$ 1.16M$ 690.00K
EBITDA
$ -238.09M$ -168.46M$ -174.25M$ -68.45M$ -135.88M
Operating Income
$ -265.50M$ -184.36M$ -179.16M$ -170.06M$ -136.57M
Other Income/Expenses
$ 5.25M$ 243.00K$ -1.96M$ 100.45M$ 2.58M
Pretax Income
$ -260.26M$ -184.11M$ -181.12M$ -69.61M$ -134.00M
Net Income
$ -260.60M$ -184.68M$ -181.12M$ -69.61M$ -130.73M
Per Share Metrics
Basic EPS
$ -4.34$ -3.20$ -3.51$ -1.37$ -2.96
Diluted EPS
$ -4.34$ -3.20$ -3.51$ -1.37$ -2.96
Weighted Average Shares Outstanding
60.99M 57.67M 52.12M 49.60M 44.13M
Weighted Average Shares Outstanding (Diluted)
60.99M 57.67M 52.12M 49.60M 44.13M
Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History